Pump Science
A decentralized platform crowdfunding anti-aging research via tokens
Performances
RD Popularity Index
RD Growth Index
Comparison
Follow Updates
Follow Lists
People
About Pump Science
Pump Science is a decentralized research project on Solana. In essence, it turns "predicting which drug can extend lifespan" into a market game the public can join. A candidate compound gets its own token for users to trade. When market cap reaches a threshold, the project starts animal tests: first lifespan in worms, then flies and mice. Experimental data (e.g., worm survival counts, fly activity) are made public in real time, so users trade tokens based on performance — effectively using the market to vote for "longevity gems."
The core problem it tackles is the high barrier, opaque funding, and poor public access in traditional science. Pump Science puts drug R&D, experimental data, and on-chain trading in one framework, letting anyone fund research, watch data, and bet on a medical narrative.
But the mechanism is also controversial: recently, tokens $RIF and $URO have fallen more than 90% from their highs, and whether the experimental data can support token prices is widely questioned. The platform is also adjusting rules — e.g., newly launched compounds use dynamic fees to deter front-running bots, and new compound public sales have been announced. Overall, the sector has cooled significantly from its earlier peak, but the project is still iterating on experiments and market mechanics.
The most significant development in the last six months was a security incident: on August 24, 2026, Pump Science was exploited after developers left a private key in the codebase; the wallet was hijacked, in connection with issues around its free token creation feature.
Officially stated future focus and roadmap: according to the established plan, the platform intends to launch an e-commerce marketplace in early 2026 to sell experimentally validated supplements, with a portion of sales revenue used to buy back and burn platform tokens; around Christmas 2026 it expects to launch about 20 new compound tokens covering more research areas; and it plans to partner with wearable-device companies to collect human data such as heart rate and muscle endurance to validate drug effects. The official docs also show the research pipeline as a standardized staged process from C. elegans to Drosophila to mice to human trials, with token market cap triggering experiment funding.
Co-founders: Paul Kohlhaas: Founder & CEO of Molecule, Founder of BIO Protocol, core contributor to VitaDAO. Entered crypto in 2016, co-founded Linum Labs, then served as Business Development Director at ConsenSys uPort; launched Pump Science at Solana Breakpoint in Sept 2024 (, ). Jillian Casalini: Co-founder, left in Mar 2026 per LinkedIn company page ().
Current core executives: Rahim0x: listed as a team member on RootData, but no public official title or bio ().